The effect of the pandemic period on Bladder Pain Syndrome patients under amitriptyline treatment

被引:2
|
作者
Sahin, Mehmet Fatih [1 ,5 ]
Ozcan, Ridvan [2 ]
Malak, Arzu [3 ]
Dogan, Cagri [4 ]
Yazici, Cenk Murat [4 ]
Ozcan, Muege [4 ]
Akgul, Murat [4 ]
机构
[1] Corlu State Hosp, Dept Urol, Corlu, Tekirdag, Turkiye
[2] Bursa City Hosp, Dept Urol, Bursa, Nilufer, Turkiye
[3] Tekirdag Namik Kemal Univ, Sch Hlth, Nursing Dept, Suleymanpasa, Tekirdag, Turkiye
[4] Tekirdag Namik Kemal Univ, Med Sch, Dept Urol, Suleymanpasa, Tekirdag, Turkiye
[5] Corlu State Hosp, Dept Urol, TR-59850 Corlu, Tekirdag, Turkiye
关键词
anxiety; bladder pain syndrome; COVID-19; depression; INTERSTITIAL CYSTITIS; ANXIETY; WOMEN;
D O I
10.1002/nau.25199
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
IntroductionCOVID-19 is a disease that may cause anxiety, depression, and stress. Bladder pain syndrome (BPS) is a disease in which stress and psychological factors might negatively affect its course. In this study, we aimed to examine the possible clinical aggregation of the pandemic period on BPS patients. Materials and MethodsA total of 35 BPS patients diagnosed between 2010 and 2018 were included. All patients were using medical treatment, and the follow-up period was at least 6 months. According to our clinical follow-up protocol, the BPS patients were given the King's Health Questionnaire (KHQ), Beck Anxiety Inventory (BAI), Beck Depression Inventory (BDI), Overactive Bladder Form V8 (OAB-V8), and Visual Analog Score (VAS) in every visit. In the sixth month of the pandemic, the clinical course of the patients was questioned by telephone or video interview, and their treatment continuities were questioned. Information was received about the delays in their follow-up and the difficulties in accessing healthcare opportunities. The same questionnaires were filled out and compared with pre-pandemic scores. ResultsThe mean age of the patients included in the study was 50.2 +/- 13.32 (min:20, max:74), 11 were males and 24 were females. The mean follow-up periods were 71.8 +/- 35.6 months. All questionnaire scores showed an increase compared to the pre-pandemic period. A statistically significant increase was detected during the pandemic in all sub-units of the KHQ. The VAS and OAB-V8 scores of 16 patients who requested hospital admission were significantly higher than before the pandemic. However, there was no statistically significant difference in the increase in VAS and OAB-V8 scores of the 19 patients who refused to come to the hospital. ConclusionBPS patients have been negatively affected by the emotional effects of the COVID-19 pandemic. Due to the fear, stress, anxiety, and depression, the symptoms of BPS patients exacerbated, and the patients could not receive the necessary support due to a lack of regular follow-ups.
引用
收藏
页码:1188 / 1193
页数:6
相关论文
共 50 条
  • [21] The Effect of a Diagnosis on Patients With Interstitial Cystitis/Bladder Pain Syndrome: A Qualitative Approach
    Volpe, Katherine A.
    Komatsu, Emi
    Rodriguez, Larissa V.
    Dancz, Christina E.
    Pahwa, Avita K.
    FEMALE PELVIC MEDICINE AND RECONSTRUCTIVE SURGERY, 2021, 27 (05): : e533 - e537
  • [22] Urgency and pain in patients with overactive bladder and bladder pain syndrome. What are the differences?
    Castro-Diaz, D.
    Cardozo, L.
    Chapple, C. R.
    Espuna, M.
    Kelleher, C.
    Kirby, M.
    Milsom, I.
    Sievert, K-D
    Tubaro, A.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2014, 68 (03) : 356 - 362
  • [23] Interventional Pain Management in the Treatment of Interstitial Cystitis/Bladder Pain Syndrome
    Kalajian, Tyler
    Drerup, Brenden
    Drerup, Jennifer
    Burke, Martin
    Selassie, Meron
    CURRENT BLADDER DYSFUNCTION REPORTS, 2025, 20 (01) : 9 - 9
  • [24] Re: Examination of the Significant Placebo Effect in the Treatment of Interstitial Cystitis/Bladder Pain Syndrome
    Zuemruetbas, Ali Ersin
    JOURNAL OF UROLOGICAL SURGERY, 2015, 2 (04): : 205 - 205
  • [25] Diagnosis and Treatment of Interstitial Cystitis/Bladder Pain Syndrome
    Clemens, J. Quentin
    Erickson, Deborah R.
    Varela, Norma P.
    Lai, H. Henry
    JOURNAL OF UROLOGY, 2022, 208 (01): : 34 - 42
  • [26] Diagnosis and Treatment of Interstitial Cystitis/Bladder Pain Syndrome
    Hanno, Philip
    JOURNAL OF UROLOGY, 2022, 208 (06):
  • [27] Urinary diversion in the treatment of refractory bladder pain syndrome
    Brandt, Simone Buchardt
    Kirkeby, Hans Jurgen
    Brandt, Anne Sofie Virring
    Jensen, Jurgen Bjerggaard
    SCANDINAVIAN JOURNAL OF UROLOGY, 2019, 53 (06) : 424 - 430
  • [28] Efficacy of citalopram or amitriptyline versus no treatment in patients with functional chest pain
    Voulgaris, Theodoros
    Lekakis, Vassileios
    Vlachogiannakos, Jiannis
    Kamberoglou, Dimitrios
    Orfanidou, Afroditi
    Papatheodoridis, George
    Karamanolis, George
    ANNALS OF GASTROENTEROLOGY, 2023, 36 (01): : 6 - 11
  • [29] Autonomic Response During Bladder Hydrodistention in Patients with Bladder Pain Syndrome
    Stav, Kobi
    Lang, Erez
    Fanus, Zacci
    Leibovici, Dan
    JOURNAL OF UROLOGY, 2012, 188 (01): : 117 - 121
  • [30] AMNIOTIC BLADDER THERAPY IN PATIENTS WITH INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME
    Madan, Raghav
    Radoiu, Codrut
    Vercnocke, Jack
    Liaw, Aron
    Lucas, Steven
    Hamada, Alaa
    Dhar, Nivedita
    JOURNAL OF UROLOGY, 2024, 211 (05): : E537 - E538